Provenance, Added Clinical Benefit and Therapeutic Area of 632 medicines that entered the French market between 2008 and 2018
Osipenko, L.
(2023).
Provenance, Added Clinical Benefit and Therapeutic Area of 632 medicines that entered the French market between 2008 and 2018.
[Dataset]. Zenodo.
https://doi.org/10.5281/zenodo.7825910
This file contains a data set of 632 medicines that entered the French market between 2008 to 2018. 529 medicines are single drugs and 103 are combination medicines. For each drug we present data on provenance (inventor of the drug) and sources referencing our searches for origins of each medicine. We also present added clinical benefit data for all 632 medicines based on HAS and Prescrire matched grading scale as well as therapeutic area of each medicinal product in which the clinical benefit grading was sourced (highest clinical benefit grading attained by the product in the indication based on Prescrire grading). The file also contains data on the medicines approved by the FDA in the United States
Explore Further
-
Osipenko, L., Potey, P., Perez, B., Kupryjanczuk, A., Angelov, F., Schuster, A. & Mossialos, E.
(2023).
Provenance and clinical benefit of medicines introduced to the French market, 2008 to 2018.
JAMA Internal Medicine,
184(1), 46 - 52.
https://doi.org/10.1001/jamainternmed.2023.6249
(Repository Output)
Downloads